Hopp Family Office

Hopp Family Office manages the private investments and wealth of SAP co-founder Dietmar Hopp, focusing on biotech ventures and other strategic opportunities. The office primarily invests in life sciences, identifying prospects through partners like Dievini consulting, which was established in 2005 by Helmut Hettich and Carl Ferdinand von Bohlen to manage Hopp's biotech portfolio. Notable investments include a €15 million allocation to liver cell therapy firm Cytonet in 2000 and stakes in companies developing drugs for colon disease and cancer, such as Cosmo. While specific assets under management for the family office are not publicly disclosed, Dietmar Hopp's personal wealth, largely derived from his SAP shares alongside co-founders Hasso Plattner and Klaus Tschira, underpins its activities. The family office's operations are overseen by Dietmar Hopp, who established the investment vehicle Dievini in 2005.